Generic Lipitor Maker Stops Production

It had to recall drug shipments twice in the last four months

   

prescription drugs 300x180 Generic Lipitor Maker Stops ProductionThe U.S. Food and Drug Administration (FDA) announced on Thursday that Ranbaxy Laboratories (PINK:RBXZF) had halted production of its generic version of Lipitor, a cholesterol drug, while it reviews operations to determine how glass particles contaminated some shipments of the medication.

No shortage in the supply of the drug — marketed as atorvastatin — was expected due to Ranbaxy’s production stoppage, the Wall Street Journal noted.

Rx Symbol 630 Flickr 200x200 Generic Lipitor Maker Stops Production
Novartis Touts Pipeline of Blockbuster Drugs

Discovery of glass particles in some bottles of atorvastatin prompted the company, which is the India-based subsidiary of Japan’s Daiichi Sankyo PINK:DSNKY), to recall a large number of shipments on November 89. That followed an August recall of 32,000 bottles of atorvastatin produced by Ranbaxy after a 20mg atorvastatin was found in a bottle marked for 10mg dosages of the drug.

So far, the FDA indicated that it had received reports of any injuries due to the glass particles.


Article printed from InvestorPlace Media, http://investorplace.com/2012/11/generic-lipitor-maker-stops-production/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.